FLT3 and neoplasm: Although it remains unknown that FLT3 amplification might be potentially actionable molecular alterations in certain tumor types, in the current study, we investigated patients with solid cancers majority of gastrointestinal malignancies harboring of FLT3 amplification and the clinical efficacy of FLT3 inhibition in this subpopulation.